Clinical trial
ZD 1839 in Treating Patients With Metastatic or Recurrent Cancer of the Head and…
NCT00015964 · University of Chicago, Other · Completed
Key facts
| NCT number | NCT00015964 |
|---|---|
| Title | ZD 1839 in Treating Patients With Metastatic or Recurrent Cancer of the Head and Neck |
| Official title | A Phase II Stdy of ZD 1839 in Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck |
| Lead sponsor | University of Chicago, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Head and Neck Cancer |
| Intervention type | Drug |
| Interventions | ZD1839 |
| Enrollment | 51 |
| Start date | Mar 1, 2001 |
| Primary completion | Sep 1, 2001 |
| Completion | Jul 1, 2005 |
| First posted | Feb 27, 2004 |
| Last update posted | Sep 5, 2013 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: